Clinical Trials Logo

Rhinoplasty clinical trials

View clinical trials related to Rhinoplasty.

Filter by:

NCT ID: NCT04773002 Completed - Hemorrhage Clinical Trials

A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA)

Start date: March 18, 2021
Phase:
Study type: Observational [Patient Registry]

In this study, investigators wanted to investigate the effect of volatile anesthesia and total intravenous anesthesia (TIVA) on ecchymosis, edema, and intraoperative bleeding in rhinoplasty.

NCT ID: NCT04512664 Completed - Nurse's Role Clinical Trials

Different Cold Application Times on Ecchmosis, Edema and Pain After Rhinoplasty

Start date: January 5, 2015
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effects of different cold application times with cold gel pads after rhinoplasty on eyelid edema, eye ecchymosis and pain. A total of 60 patients undergoing rhinoplasty were divided into two groups by simple randomization method. Cold application applied to short term group for 4 hours and to long term group for 48 hours. Cold application was applied around both eyes with cold gel pads for 20 minutes per hour. Pain was evaluated with the Visuel Analog Scale, ecchymosis with eyelid ecchymosis score, and edema with eye-edema score. Edema and ecchymosis were evaluated on the 1st and 4th hours and 2nd day. Pain conditions were evaluated before and after analgesics for 1, 4 hours and 2 times daily.

NCT ID: NCT04499469 Recruiting - Nasal Obstruction Clinical Trials

The Role of Spreader Grafts in Reduction Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Assessment

Start date: October 3, 2018
Phase: N/A
Study type: Interventional

Nasal obstruction is one of the majors concerns in reduction rhinoseptoplasty, because it affects quality of life and surgical outcomes. Is the association of middle third grafts with reduction rhinoseptoplasty responsible for an increase in quality of life related to nasal obstruction when compared to reduction rhinoseptoplasty without the placement of these grafts?

NCT ID: NCT04457765 Withdrawn - Rhinoplasty Clinical Trials

Betadine Effect on Nasal Mucosa Cilia

Start date: April 2021
Phase: Early Phase 1
Study type: Interventional

The goal of the proposed study is to identify PVP-I at 1.25% as an appropriate intranasal topical preparation for patients undergoing rhinoplasty with no effect on the nasal mucosa cilia (NMC) or olfaction using the saccharin transit time (STT) test as a method for evaluating NMC function. PVP-I has been shown to be viricidal in the upper aerodigestive tract. This study is highly-relevant, as protection for individuals with a high risk of exposure to respiratory pathogens has become increasingly important in the setting of recent viral epidemics such as SARS-CoV-2. Septorhinoplasty is commonly performed throughout the world and there is a paucity of standardized testing in surgical facilities. Much of our understanding of the current COVID-19 pandemic is extrapolated from MERS and SARS data. It is our hope that this study's relevance for the current pandemic remains so in the unfortunate event of another pandemic in the future.

NCT ID: NCT03925389 Recruiting - Nasal Obstruction Clinical Trials

Outcome Analysis in Septorhinoplasty

Start date: May 7, 2019
Phase:
Study type: Observational

A prospective observational cohort study that measures pre- and postoperative outcome of septorhinoplasty by means of patient-related outcome measures (PROMS: NOSE, FACE-Q, Utrecht Questionnaire, SCHNOS and BDDQ-AS) as well as with functional tests (NAR, AR, PNIF).

NCT ID: NCT03584503 Completed - Rhinoplasty Clinical Trials

Effect of Use of Endotracheal Tube With Subglottic Suction in Rhinoplasty

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Suction Above Cuff Endotracheal Tube (SACETT) has a dorsal port above the cuff designed to allow continuous or intermittent suctioning of secretions from the subglottic space. Thus, it facilitates suctioning of excessive secretions around the mouth and the cuff. In this study, we aimed to investigate the effect of the use of SACETT on laryngospasm and postoperative complications in rhinoplasty operations. This randomized controlled clinical trial was conducted in 132 patients undergoing rhinoplasty. The investigators believe that the use of SACETT in rhinoplasty operations reduces the incidences of laryngospasm, emergence agitation, sore throat, swallowing difficulty, and PONV when compared with classic endotracheal tube.

NCT ID: NCT03519100 Recruiting - Quality of Life Clinical Trials

Rhinoplasty and Quality of Life

FACE-Q
Start date: January 8, 2018
Phase:
Study type: Observational

Quality of life and satisfaction in aesthetic surgery is still under-evaluated. It is a prospective and multicenter study with a 4 months follow-up of patients under rhinoplasty or rhinoseptoplasty procedure. They will answer to the FACE-Q and NOSE questionnaires before surgery, one week later and 4 months after the procedure. The aim of the study is to show a significant augmentation of the quality of life scores. At this occasion, the FACE-Q questionnaire has been translated and validated in French

NCT ID: NCT03457116 Completed - Opioid Use Clinical Trials

Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty

Start date: January 30, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This study will also evaluate potential contributing factors affecting the efficacy of these pain control methods. Patients will be randomized to receive either NSAIDs in the form of 400mg of Ibuprofen or Norco (hydrocodone 5mg- acetaminophen 325mg) to be used for post-operative pain. The study will then compare which is more effective in controlling post operative pain.

NCT ID: NCT03213548 Not yet recruiting - Clinical trials for Surgical Procedure, Unspecified

Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty

Start date: September 15, 2017
Phase: N/A
Study type: Interventional

Rhinoplasty is among the most accomplished aesthetic procedures in Plastic Surgery. The mastery of Alar Base modifications is essential for superior aesthetic results. The main indication is to reduce nasal width when it exceeds the intercanthal distance in Caucasian women. Other indications are the modification of the shape of the nostrils or to reduce alar flare in noses with too convex alar base. Since Wier's first description, a series of techniques has been developed with a common goal of making the basal view of the nose close to an equilateral triangle. The location and amount of tissue to be removed will be according to the preoperative or intraoperative indication due to changes in the alar base resulting from reductions in the projection of the nasal tip. One of the controversies in the literature is in the position of the incision in alar base modifications. Some authors prioritize incisions that do not violate the alar facial groove , since the groove region presents a greater number of sebaceous glands, leading to poor scarring results. Other authors have argued that incisions above the sulcus have caused more evident scars, anda that poor healing results would be more associated with aggressive resections of border and bad closing skin techniques. Due to divergence in the literature, the present study aims to compare, through a double blinded randomized clinical trial, two techniques of alar base modifications that will differentiate only by violating or not the alar facial groove.

NCT ID: NCT02822781 Completed - RHINOPLASTY Clinical Trials

Chronic Rhinosinusitis Classification Proposal

Start date: November 1, 2015
Phase: N/A
Study type: Observational

Chronic rhinosinusitis (CRS) is a debilitating disease that remains (smell, nasal patency, flow) because currently treatment protocols available to us are with a limited efficacy. The assessment of the response to surgical treatment protocols and monitoring the become of patients treated with only drugs should allow investigators to identify the predictive patient's profile for the response. With this prospective data, this study would allow investigators to make a classification of Chronic rhinosinusitis.